Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
Primary Purpose
HIV Infections, Diabetes, Depression
Status
Completed
Phase
Phase 1
Locations
India
Study Type
Interventional
Intervention
Yoga
Sponsored by

About this trial
This is an interventional treatment trial for HIV Infections focused on measuring Yoga, Meditation
Eligibility Criteria
Inclusion Criteria for Study 1 Participants: Meet certain laboratory requirements Inclusion Criteria for Study 2 Participants: HIV infected Able to walk at least 50% of the time Inclusion Criteria for All Participants: Written informed consent of parent/guardian, if applicable Exclusion Criteria for Study 2 Participants: Require antiretroviral therapy
Sites / Locations
- Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA)
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00090506
First Posted
August 26, 2004
Last Updated
January 23, 2008
Sponsor
National Center for Complementary and Integrative Health (NCCIH)
1. Study Identification
Unique Protocol Identification Number
NCT00090506
Brief Title
Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
Official Title
Yoga, Health, and Meditation
Study Type
Interventional
2. Study Status
Record Verification Date
January 2008
Overall Recruitment Status
Completed
Study Start Date
July 2004 (undefined)
Primary Completion Date
March 2007 (Actual)
Study Completion Date
March 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Center for Complementary and Integrative Health (NCCIH)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.
Detailed Description
In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.
Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections, Diabetes, Depression
Keywords
Yoga, Meditation
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
50 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Yoga
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria for Study 1 Participants:
Meet certain laboratory requirements
Inclusion Criteria for Study 2 Participants:
HIV infected
Able to walk at least 50% of the time
Inclusion Criteria for All Participants:
Written informed consent of parent/guardian, if applicable
Exclusion Criteria for Study 2 Participants:
Require antiretroviral therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frederick M. Hecht, MD
Organizational Affiliation
UCSF Positive Health Program
Official's Role
Principal Investigator
Facility Information:
Facility Name
Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA)
City
Bangalore
Country
India
12. IPD Sharing Statement
Citations:
PubMed Identifier
24980650
Citation
McDermott KA, Rao MR, Nagarathna R, Murphy EJ, Burke A, Nagendra RH, Hecht FM. A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial. BMC Complement Altern Med. 2014 Jul 1;14:212. doi: 10.1186/1472-6882-14-212.
Results Reference
derived
Learn more about this trial
Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
We'll reach out to this number within 24 hrs